Pancreatic Cancer Research

Journal articleEur Rev Med Pharmacol Sci2021

Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer.

Journal
Eur Rev Med Pharmacol Sci
Published
1 August 2021
Citations
3
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Objective To investigate the efficacies and mechanisms of combination therapy with interleukin-15 (IL-15) and metformin (Met) on suppressing pancreatic cell proliferation and protecting Panc02-bearing mice. Materials and methods MTT assays were applied to assess the inhibitory effects of IL-15 combined Met or Met and IL-15 alone on proliferation of normal HPDE6-C7 and Panc02 cells. … Excerpt only: this text is the publisher’s. Read it in full at the source.